Company Fact Sheet
| Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company employs approximately 4,700 scientists and other professionals and had revenues of approximately $1.3 billion in 2007. |
Headquarters
-
Invitrogen Corporation
5791 Van Allen Way
Carlsbad, California 92008
Phone: (760) 603-7200
Fax: (760) 602-6500
www.invitrogen.com
Invitrogen has more than fifteen manufacturing locations in North America, Europe and Asia, and does business in more than 70 countries worldwide.
Global Contacts.
Corporate Management
-
Gregory T. Lucier - Chairman and Chief Executive Officer
David F. Hoffmeister - Senior Vice President, Chief Financial Officer
Nicolas M. Barthelemy - Senior Vice President, Cell Culture Systems
Joseph Beery - Senior Vice President, Chief Information Officer
Claude D. Benchimol, Ph.D. - Senior Vice President, Advanced Systems, Research & Development
Bernd Brust - Senior Vice President, Global Sales and Marketing
John A. Cottingham - Senior Vice President, General Counsel and Corporate Secretary
Paul Grossman , Ph.D. - Senior Vice President, Strategy and Corporate Development
Peter Leddy, Ph.D. - Senior Vice President, Human Resources
Kip Miller - Senior Vice President, BioDiscovery
Kelli Richard - Vice President, Finance & Chief Accounting Officer
Amanda Clardy - Vice President, Investor Relations
Employees: Over 4,700 worldwide
Sales: Revenues of $1.3 billion for 2007
Media Contacts
-
Farnaz Khadem
Director, Corporate Communications
Phone: 760.603.7245
Email: farnaz.khadem@invitrogen.com
Revelle Bailey
Public Relations Manager
Phone: 760.268.7482
Mobile: 760.429.4360
Email: revelle.bailey@invitrogen.com



